Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and schizandrin b

daunorubicin has been researched along with schizandrin b in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, X; Lu, Q; Qiangrong, P; Wang, T1
Hu, X; Lu, Q; Pan, Q; Zhang, K1
Hu, X; Lu, Q; Pan, Q; Sun, M; Xu, X1

Other Studies

3 other study(ies) available for daunorubicin and schizandrin b

ArticleYear
Schisandrin B--a novel inhibitor of P-glycoprotein.
    Biochemical and biophysical research communications, 2005, Sep-23, Volume: 335, Issue:2

    Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Models, Chemical; Neoplasms; Polycyclic Compounds; Protein Binding; Tetrazolium Salts; Thiazoles; Time Factors

2005
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:1

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dioxoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Paclitaxel; Polycyclic Compounds; Prohibitins; Vincristine

2006
Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
    Cancer letters, 2007, Feb-08, Volume: 246, Issue:1-2

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclooctanes; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lignans; Molecular Structure; Multidrug Resistance-Associated Proteins; Polycyclic Compounds; Probenecid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2007